BackOrphazyme A/S Overview

Orphazyme A/S Total Assets

Track Orphazyme A/S's total assets ($18M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$17.85M
↓ 50.66% YoYΔ $-18.33M vs prior year quarter

Peer average

Loading

Orphazyme A/S Total Assets History

Loading

Orphazyme A/S vs. peers: Total Assets Comparison

Loading

Orphazyme A/S Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Orphazyme A/S (ORPHY) FAQ

Orphazyme A/S posts a total assets of $18M as of June 2024. That compares with $36M in the prior-year period — down 50.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Orphazyme A/S's total assets was $36M. The latest reading is $18M — a 50.7% year-over-year decrease (period ending June 2024). Use the history and growth charts on this page for a longer lookback.

Total Assets is one piece of Orphazyme A/S's financial statement story. At $18M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ORPHY's total assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Orphazyme A/S's other metric pages and overview cover the third.

Judging Orphazyme A/S against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in total assets easier to interpret. Start with $18M here, then scan peer and history charts to see if the gap is persistent.